Back

Where to list is one of the most significant decisions a growing European company can make, and US capital markets sometimes feature in that conversation. To help companies make that choice on evidence rather than perception, Euronext publishes the third edition of its analysis on the topic, providing a data-driven overview of why Euronext markets deliver better outcomes for European companies.

The study draws on BMLL, Dealogic, FactSet and Euronext data, as of 30 June 2026. It covers every European IPO in the US since 2021, as well as European companies with their primary listing in the US, and compares their outcomes with those of peers on Euronext.

 

Listing in Europe vs. the US
 

Download the document

 

Key findings

 

European IPOs in the US are marginal and concentrated.

  • A marginal flow: fewer than 5% of European IPOs have taken place in the US since 2021 – 45 companies, against 900+ in Europe – with no upward trend since 2018 outside of the 2021 global peak.

  • A concentrated profile: 62% came from the UK, Germany and Switzerland, and nearly half were healthcare companies whose key commercial market is the US.

The data suggests most would have fared better in Europe.

  • Weak aftermarket performance: 71% of European IPOs in the US trade, or were delisted, below their offer price, with one-year post-listing performance of -28%, against +3% on Euronext.

  • No valuation premium: Euronext issuers trade at a premium below €10bn in market capitalisation, the range covering 80% of European companies listed in the US.

  • No liquidity premium: free-float velocity is comparable across both markets for European companies.

Euronext offers similar access to global capital without giving up the European investor base, at materially lower cost.

  • US investors are already on Euronext: they represent almost a third of institutional ownership.

  • Higher cost and governance burden in the US: IPO fees, governance costs and litigation exposure are all significantly higher when compared to Europe.

  • Lower likelihood of flagship index inclusion: most European companies do not meet the criteria for US flagship indices, while many would qualify for leading European ones.

     

For most European companies, a US listing delivers no systematic advantage in terms of performance, valuation or liquidity. Download the full analysis for more information.